Novavax is trading 5.24% up at $9.88, primarily as biotechnology stocks strengthen alongside broader sector gains.
- The XBI sector ETF is up 2.55% during regular trading amid a stronger industry outlook and M&A optimism.
- No fresh company-specific announcement was identified for September 17, 2026.
- Recent coverage centers on licensing partnerships and investor conferences, rather than a new intraday catalyst.